James Frates, SVP, Alks Inc; CFO ALKS at Alkermes, holds 306.96K shares in Amylyx Pharmaceuticals Inc (Ticker: AMLX), holds 0.00 shares in SAGE Therapeutics (Ticker: SAGE), holds 247.50K shares in Alkermes (Ticker: ALKS). Most recently, James Frates Sold ― shares of Amylyx Pharmaceuticals Inc on Oct 02, 2025 for an estimated value of $154.57K.
What is the percentage of profitable transactions made by James Frates?
The percentage of profitable transactions made by James Frates is 57%.
What is the average return per transaction made by James Frates?
The average return per transaction made by James Frates is 5.50%.
What stocks does James Frates hold?
James Frates holds: ALKS, AMLX, SAGE stocks.
What was James Frates’s latest transaction?
James Frates latest transaction was an Informative Sell of $154.57K.
What was James Frates's most profitable transaction?
James Frates’s most profitable transaction was an Informative Buy of SAGE stock on July 23, 2014. The return on the trade was 173.30%.
What is James Frates's role in Alkermes?
James Frates's role in Alkermes is SVP, Alks Inc; CFO ALKS.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.